Association of delays in surgery for melanoma with insurance type

JAMA Dermatology

Volumn 153, Issue 11, 2017, Pages 1106-1113

  Adamson, Adewole S ^a,b   Zhou, Lei ^b   Baggett, Christopher D ^b,c   Thomas, Nancy E ^a,b   Meyer, Anne Marie ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CUTANEOUS MELANOMA; DOCTOR PATIENT RELATION; EXCISION; FEMALE; HEALTH INSURANCE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NORTH CAROLINA; POPULATION RESEARCH; PRIORITY JOURNAL; PRIVATE INSURANCE; SKIN BIOPSY; SUGICAL DELAY; THERAPY DELAY; AGED; COMPARATIVE STUDY; DERMATOLOGIST; HEALTH CARE QUALITY; MELANOMA; MIDDLE AGED; PATHOLOGY; REGISTER; RETROSPECTIVE STUDY; SKIN TUMOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DERMATOLOGISTS; FEMALE; HUMANS; INSURANCE, HEALTH; LINEAR MODELS; MALE; MEDICAID; MEDICARE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NORTH CAROLINA; QUALITY OF HEALTH CARE; REGISTRIES; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME-TO-TREATMENT; UNITED STATES;

EID: 85034644512     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2017.3338     Document Type: Article

References (33)

1. Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013;2(1):24-34.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
3. Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253 (4):779-785.
4. Korsgaard M, Pedersen L, Sørensen HT, Laurberg S. Delay of treatment is associated with advanced stage of rectal cancer but not of colon cancer. Cancer Detect Prev. 2006;30(4):341-346.
5. Bardell T, Belliveau P, Kong W, Mackillop WJ. Waiting times for cancer surgery in Ontario: 1984-2000. Clin Oncol (R Coll Radiol). 2006;18(5): 401-409.
6. Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioners’ referrals: retrospective national survey. BMJ. 2000;320(7238):838-839.
7. Lott JP, Narayan D, Soulos PR, Aminawung J, Gross CP. Delay of surgery for melanoma among Medicare beneficiaries. JAMA Dermatol. 2015;151 (7):731-741.
8. Huff LS, Chang CA, Thomas JF, et al. Defining an acceptable period of time from melanoma biopsy to excision. Dermatol Reports. 2012;4(1):e2.
9. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/archive/csr/1975_2013/. Accessed January 17, 2017.
10. Spencer CS, Gaskin DJ, Roberts ET. The quality of care delivered to patients within the same hospital varies by insurance type. Health Aff (Millwood). 2013;32(10):1731-1739.
11. LaPar DJ, Bhamidipati CM, Mery CM, et al. Primary payer status affects mortality for major surgical operations. Ann Surg. 2010;252(3):544-550.
12. Amini A, Rusthoven CG, Waxweiler TV, et al. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States. J Am Acad Dermatol. 2016;74(2): 309-316.
13. Meyer AM, Olshan AF, Green L, et al. Big data for population-based cancer research: the integrated cancer information and surveillance system. N C Med J. 2014;75(4):265-269.
14. Goyal RK, Wheeler SB, Kohler RE, et al. Health care utilization from chemotherapy-related adverse events among low-income breast cancer patients: effect of enrollment in a medical home program. N C Med J. 2014;75(4):231-238.
15. Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM. Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer. N C Med J. 2014;75(4): 239-246.
16. Doll KM, Meng K, Basch EM, Gehrig PA, Brewster WR, Meyer AM. Gynecologic cancer outcomes in the elderly poor: a population-based study. Cancer. 2015;121(20):3591-3599.
17. Doll KM, Meng K, Gehrig PA, Brewster WR, Meyer AM. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women. Am J Obstet Gynecol. 2016;215(4): 447.e1-447.e13.
18. Doll KM, Basch EM, Meng K, et al. Clinical benefits associated with Medicaid coverage before diagnosis of gynecologic cancers. J Oncol Pract. 2016;12(6):e724-e733.
19. Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005;95(7):1149-1155.
20. Fedewa SA, Lerro C, Chase D, Ward EM. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol. 2011;122(1):63-68.
21. Simard EP, Fedewa S, Ma J, Siegel R, Jemal A. Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer. 2012;118(20):5110-5116.
22. Halpern MT, Holden DJ. Disparities in timeliness of care for US Medicare patients diagnosed with cancer. Curr Oncol. 2012;19(6):e404-e413.
23. Tsai S, Balch C, Lange J. Epidemiology and treatment of melanoma in elderly patients. Nat Rev Clin Oncol. 2010;7(3):148-152.
24. Pollack LA, Li J, Berkowitz Z, et al. Melanoma survival in the United States, 1992 to 2005. J Am Acad Dermatol. 2011;65(5)(suppl 1):S78-S86.
25. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26(1):66-75.
26. Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol. 2007;143(4): 488-494.
27. McKenna DB, Marioni JC, Lee RJ, Prescott RJ, Doherty VR. A comparison of dermatologists’, surgeons’ and general practitioners’ surgical management of cutaneous melanoma. Br J Dermatol. 2004;151(3):636-644.
28. McKenna DB, Lee RJ, Prescott RJ, Doherty VR. The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival. Br J Dermatol. 2002;147(1):48-54.
29. Carpenter S, Pockaj B, Dueck A, et al. Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome? Am J Surg. 2008;196(6):834-842.
30. Rosenbaum S. Medicaid payments and access to care. N Engl J Med. 2014;371(25):2345-2347.
31. Felland LE, Lechner AE, Sommers A. Improving access to specialty care for Medicaid patients: policy issues and options. New York, NY: The Commonwealth Fund; 2013. https://pdfs.semanticscholar.org/cd46/56b7a62779a8afa7b16574f7758bb76c6075.pdf. Accessed December 10, 2016.
32. Resneck J Jr, Pletcher MJ, Lozano N. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol. 2004;50(1):85-92.
33. Chaudhry SB, Armbrecht ES, Shin Y, et al. Pediatric access to dermatologists: Medicaid versus private insurance. J Am Acad Dermatol. 2013;68 (5):738-748.